Lisa Kinget

Laboratorium Experimentele Oncologie

ON4 Herestraat 49 - bus 815

3000 Leuven

KU Leuven kaart

Functies


Curriculum Vitae

 

 

Recente publicaties

  • launch Montemagno, C., Jacquel, A., Pandiani, C., Rastoin, O., Dawaliby, R., Schmitt, T., Bourgoin, M., Palenzuela, H., Rossi, A-L., Ambrosetti, D., Durivault, J., Luciano, F., Borchiellini, D., Le Du, J., Gonçalves, L.C P., Auberger, P., Benhida, R., Kinget, L., Beuselinck, B., Ronco, C., Pagès, G., Dufies, M. (2024). Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001. J Exp Clin Cancer Res, 43 (1). doi: 10.1186/s13046-024-02984-2
  • launch Sprooten, J., Laureano, R.S., Vanmeerbeek, I., Govaerts, J., Naulaerts, S., Borras, D.M., Kinget, L., Fucikova, J., Spisek, R., Jelinkova, L.P., Kepp, O., Kroemer, G., Krysko, D.V., Coosemans, A., Vaes, R.D W., De Ruysscher, D., De Vleeschouwer, S., Wauters, E., Smits, E., Tejpar, S., Beuselinck, B., Hatse, S., Wildiers, H., Clement, P.M., Vandenabeele, P., Zitvogel, L., Garg, A.D. with Garg, A.D. (corresp. author) (2023). Trial watch: chemotherapy-induced immunogenic cell death in oncology. ONCOIMMUNOLOGY, 12 (1), Art.No. ARTN 2219591. doi: 10.1080/2162402X.2023.2219591 openaccessvia repository
  • launch Kinget, L., Naulaerts, S., Govaerts, J., Vanmeerbeek, I., Sprooten, J., Laureano, R.S., Roussel, E., Verbiest, A.T L., Lambrechts, D., Boeckx, B., Zucman-Rossi, J., Albersen, M., Baldewijns, M., Tejpar, S., Beuselinck, B., Garg, A.D. (2023). Multi-omics mapping positions antigenic myeloid-T cell crosstalk at the core of advanced renal cell carcinoma (aRCC) response to immune checkpoint blockade (ICB). In: ANNALS OF ONCOLOGY: vol. 34, (S1026-S1027). Presented at the Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), SPAIN, Barcelona, 20 Oct 2023-24 Oct 2023. doi: 10.1016/j.annonc.2023.09.1137 openaccessvia repository
  • launch Brackenier, C., Kinget, L., Cappuyns, S., Verslype, C., Beuselinck, B., Dekervel, J. with Dekervel, J. (corresp. author) (2023). Unraveling the Synergy between Atezolizumab and Bevacizumab for the Treatment of Hepatocellular Carcinoma. CANCERS, 15 (2), Art.No. ARTN 348. doi: 10.3390/cancers15020348 openaccessvia repository
  • launch Laureano, R.S., Sprooten, J., Vanmeerbeerk, I., Borras, D.M., Govaerts, J., Naulaerts, S., Berneman, Z.N., Beuselinck, B., Bol, K.F., Borst, J., Coosemans, A., Datsi, A., Faucikova, J., Kinget, L., Neyns, B., Schreibelt, G., Smits, E., Sorg, R., Spisek, R., Thielemans, K., Tuyaerts, S., De Vleeschouwer, S., de Vries, I.J M., Xiao, Y., Garg, A.D. with Garg, A.D. (corresp. author) (2022). Trial watch: Dendritic cell (DC)-based immunotherapy for cancer. ONCOIMMUNOLOGY, 11 (1), Art.No. ARTN 2096363. doi: 10.1080/2162402X.2022.2096363 openaccessvia repository
  • launch Kinget, L., Roussel, E., Verbiest, A.T L., Lambrechts, D., Boeckx, B., Zucman-Rossi, J., Couchy, G., Caruso, S., Baldewijns, M., De Wever, L., Albersen, M., Beuselinck, B. (2022). Clearseq1-4 classifier in localized and metastatic clear-cell renal cell carcinoma (ccRCC). In: ANNALS OF ONCOLOGY: vol. 33 (7), (S1222-S1223). Presented at the Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), ELECTR NETWORK, 09 Sep 2022-13 Sep 2022. doi: 10.1016/j.annonc.2022.07.1581
  • launch Roussel, E., Kinget, L., Verbiest, A., Zucman-Rossi, J., Boeckx, B., Joniau, S., Lambrechts, D., Albersen, M., Beuselinck, B. with Albersen, M. (corresp. author) (2022). Molecular Heterogeneity Between Paired Primary and Metastatic Lesions from Clear Cell Renal Cell Carcinoma. EUROPEAN UROLOGY OPEN SCIENCE, 40, 54-57. doi: 10.1016/j.euros.2022.04.004 openaccessvia repository
  • launch Roussel, E., Kinget, L., Beuselinck, B., Albersen, M., Wells, C., Ernst, M.S., Donskov, F., Schmidt, A.L., Szabados, B., Pal, S.K., Meza, L.A., Agarwal, N., Weickhardt, A.J., Davis, I.D., Alva, A.S., Wood, L., Porta, C., Choueiri, T.K., Heng, D.Y C., Navani, V. (2022). First-line therapy for metastatic renal cell carcinoma with pancreatic metastases: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC). In: Journal of Clinical Oncology: vol. 40 (6_suppl), (317-317). Presented at the ASCO GU, San Francisco. doi: 10.1200/JCO.2022.40.6_suppl.317
  • launch Roussel, E., Kinget, L., Verbiest, A., Boeckx, B., Couchy, G., Caruso, S., Zucman-Rossi, J., Baldewijns, M., Joniau, S., Van Poppel, H., Lambrechts, D., Albersen, M., Beuselinck, B. (2022). Prognostic impact of clear cell renal cell carcinoma molecular subtypes determined on formalin-fixed paraffin-embedded tissue samples on outcome after complete surgical metastasectomy. In: EUROPEAN UROLOGY: vol. 81, (S586-S587).
  • launch Roussel, E., Kinget, L., Verbiest, A., Boeckx, B., Zucman-Rossi, J., Couchy, G., Caruso, S., Baldewijns, M., Joniau, S., Van Poppel, H., Lambrechts, D., Albersen, M., Beuselinck, B. with Beuselinck, B. (corresp. author) (2021). Molecular underpinnings of glandular tropism in metastatic clear cell renal cell carcinoma: therapeutic implications. ACTA ONCOLOGICA, 60 (11), 1499-1506. doi: 10.1080/0284186X.2021.1962971

Recente publicaties

  • launch Montemagno, C., Jacquel, A., Pandiani, C., Rastoin, O., Dawaliby, R., Schmitt, T., Bourgoin, M., Palenzuela, H., Rossi, A-L., Ambrosetti, D., Durivault, J., Luciano, F., Borchiellini, D., Le Du, J., Gonçalves, L.C P., Auberger, P., Benhida, R., Kinget, L., Beuselinck, B., Ronco, C., Pagès, G., Dufies, M. (2024). Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001. J Exp Clin Cancer Res, 43 (1). doi: 10.1186/s13046-024-02984-2
  • launch Sprooten, J., Laureano, R.S., Vanmeerbeek, I., Govaerts, J., Naulaerts, S., Borras, D.M., Kinget, L., Fucikova, J., Spisek, R., Jelinkova, L.P., Kepp, O., Kroemer, G., Krysko, D.V., Coosemans, A., Vaes, R.D W., De Ruysscher, D., De Vleeschouwer, S., Wauters, E., Smits, E., Tejpar, S., Beuselinck, B., Hatse, S., Wildiers, H., Clement, P.M., Vandenabeele, P., Zitvogel, L., Garg, A.D. with Garg, A.D. (corresp. author) (2023). Trial watch: chemotherapy-induced immunogenic cell death in oncology. ONCOIMMUNOLOGY, 12 (1), Art.No. ARTN 2219591. doi: 10.1080/2162402X.2023.2219591 openaccessvia repository
  • launch Kinget, L., Naulaerts, S., Govaerts, J., Vanmeerbeek, I., Sprooten, J., Laureano, R.S., Roussel, E., Verbiest, A.T L., Lambrechts, D., Boeckx, B., Zucman-Rossi, J., Albersen, M., Baldewijns, M., Tejpar, S., Beuselinck, B., Garg, A.D. (2023). Multi-omics mapping positions antigenic myeloid-T cell crosstalk at the core of advanced renal cell carcinoma (aRCC) response to immune checkpoint blockade (ICB). In: ANNALS OF ONCOLOGY: vol. 34, (S1026-S1027). Presented at the Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), SPAIN, Barcelona, 20 Oct 2023-24 Oct 2023. doi: 10.1016/j.annonc.2023.09.1137 openaccessvia repository
  • launch Brackenier, C., Kinget, L., Cappuyns, S., Verslype, C., Beuselinck, B., Dekervel, J. with Dekervel, J. (corresp. author) (2023). Unraveling the Synergy between Atezolizumab and Bevacizumab for the Treatment of Hepatocellular Carcinoma. CANCERS, 15 (2), Art.No. ARTN 348. doi: 10.3390/cancers15020348 openaccessvia repository
  • launch Laureano, R.S., Sprooten, J., Vanmeerbeerk, I., Borras, D.M., Govaerts, J., Naulaerts, S., Berneman, Z.N., Beuselinck, B., Bol, K.F., Borst, J., Coosemans, A., Datsi, A., Faucikova, J., Kinget, L., Neyns, B., Schreibelt, G., Smits, E., Sorg, R., Spisek, R., Thielemans, K., Tuyaerts, S., De Vleeschouwer, S., de Vries, I.J M., Xiao, Y., Garg, A.D. with Garg, A.D. (corresp. author) (2022). Trial watch: Dendritic cell (DC)-based immunotherapy for cancer. ONCOIMMUNOLOGY, 11 (1), Art.No. ARTN 2096363. doi: 10.1080/2162402X.2022.2096363 openaccessvia repository
  • launch Kinget, L., Roussel, E., Verbiest, A.T L., Lambrechts, D., Boeckx, B., Zucman-Rossi, J., Couchy, G., Caruso, S., Baldewijns, M., De Wever, L., Albersen, M., Beuselinck, B. (2022). Clearseq1-4 classifier in localized and metastatic clear-cell renal cell carcinoma (ccRCC). In: ANNALS OF ONCOLOGY: vol. 33 (7), (S1222-S1223). Presented at the Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), ELECTR NETWORK, 09 Sep 2022-13 Sep 2022. doi: 10.1016/j.annonc.2022.07.1581
  • launch Roussel, E., Kinget, L., Verbiest, A., Zucman-Rossi, J., Boeckx, B., Joniau, S., Lambrechts, D., Albersen, M., Beuselinck, B. with Albersen, M. (corresp. author) (2022). Molecular Heterogeneity Between Paired Primary and Metastatic Lesions from Clear Cell Renal Cell Carcinoma. EUROPEAN UROLOGY OPEN SCIENCE, 40, 54-57. doi: 10.1016/j.euros.2022.04.004 openaccessvia repository
  • launch Roussel, E., Kinget, L., Beuselinck, B., Albersen, M., Wells, C., Ernst, M.S., Donskov, F., Schmidt, A.L., Szabados, B., Pal, S.K., Meza, L.A., Agarwal, N., Weickhardt, A.J., Davis, I.D., Alva, A.S., Wood, L., Porta, C., Choueiri, T.K., Heng, D.Y C., Navani, V. (2022). First-line therapy for metastatic renal cell carcinoma with pancreatic metastases: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC). In: Journal of Clinical Oncology: vol. 40 (6_suppl), (317-317). Presented at the ASCO GU, San Francisco. doi: 10.1200/JCO.2022.40.6_suppl.317
  • launch Roussel, E., Kinget, L., Verbiest, A., Boeckx, B., Couchy, G., Caruso, S., Zucman-Rossi, J., Baldewijns, M., Joniau, S., Van Poppel, H., Lambrechts, D., Albersen, M., Beuselinck, B. (2022). Prognostic impact of clear cell renal cell carcinoma molecular subtypes determined on formalin-fixed paraffin-embedded tissue samples on outcome after complete surgical metastasectomy. In: EUROPEAN UROLOGY: vol. 81, (S586-S587).
  • launch Roussel, E., Kinget, L., Verbiest, A., Boeckx, B., Zucman-Rossi, J., Couchy, G., Caruso, S., Baldewijns, M., Joniau, S., Van Poppel, H., Lambrechts, D., Albersen, M., Beuselinck, B. with Beuselinck, B. (corresp. author) (2021). Molecular underpinnings of glandular tropism in metastatic clear cell renal cell carcinoma: therapeutic implications. ACTA ONCOLOGICA, 60 (11), 1499-1506. doi: 10.1080/0284186X.2021.1962971